adjust model reflect covid-rel disrupt retail/pharmaci
 pbm busi off-set lower aetna steep declin doc offic
visit impact rx trend believ volum fulli recov
post-covid also concern elev unemploy could impact aetna
commerci enrol even covid taper increas telehealth adopt could
pose challeng healthhub strategi
model updat adjust covid impact updat model reflect
expect drag rx volum begin late march result
covid pandem assumpt revis model covid caus drag
overal healthcar util earli post-covid also expect ramp
physician offic visit slower surgeri hospit visit
temper recoveri outlook
like drag also adjust estim reflect
view elev unemploy result loss employer-bas health
insur coverag result drag physician offic visit would translat
reduct retail prescript volum recogn chronic script
provid stabil overal volum ad hoc prescript like see declin
demand patient avoid medic visit due chang coverag employ
situat person financ addit expect high unemploy result
loss commerci live aetna insur busi
pleas see analyst certif import disclosur inform inform regard statu non-u analyst
page report
volum pbm retail segment
lower provid nt upsid
aetna perform slump commerci
market share gain relat cvss inclus partd
network continu challeng
increas competit pbm space lower
brand inflat like caus pbm revenu
decreas
largest specialti pharmaci dispens
industri expect strength continu
lift earlier anticip
unemploy rebound faster expect limit
lt impact aetna busi
prefer partnership script gain continu
off-set issu busi
front-end abl leverag traffic associ
continu transfer part-d script
posit ss sale cours
strong pbm sell season posit
growth
expect
bring claim/script volum lower
market share loss lead deceler rx volum
pbm selling-season win weaker
expand scale pillpack quicker
lower covid lock-down period deafen
nt loss increas unemploy hurt aet
segment pbm retail volum
increas competit pbm space
degrad
challeng busi limit oper
incom upsid retail pharmaci segment
multipl expans hing larg management
abil execut strategi combin cvs/
aet entiti process like take year
pleas see import disclosur inform page report
pleas see import disclosur inform page report
 dollar million unless otherwis indic -fiscal year end growth good expens expens incom alloc part incom averag dilut ep fulli growth growth size statementnet good expens expens incom tax incom exhibit balanc sheet
pleas see import disclosur inform page report
 dollar million unless otherwis indic -fiscal year end note current properti account leas right-of-us incom tax asset discount care cost portion oper leas matur long-term expens current current term term oper leas account tax long term sharehold liabil exhibit statement
pleas see import disclosur inform page report
 dollar million unless otherwis indic -fiscal year end incom less non-cash work flow oper leaseback transact net pp sale invest flow invest issuanc issuanc financ flow financ exchang rate increas decreas growth equiti research
approxim retail locat approxim walk-in medic clinic lead pharmaci benefit manag
approxim million plan member dedic senior pharmaci care busi serv one million patient per year
expand specialti pharmaci servic also serv estim million peopl tradit voluntari
consumer-direct health insur product relat servic
pt deriv appli average ev/ebitda ratio ebitda estim risk headlin compstore
pressur gross margin compress
brian tanquilut certifi view express research report accur reflect person view subject
secur subject compani also certifi part compens directli indirectli relat
specif recommend view express research report
jason plagman certifi view express research report accur reflect person view subject
secur subject compani also certifi part compens directli indirectli relat
specif recommend view express research report
case jefferi employe analyst respons coverag financi instrument discuss
report receiv compens base part overal perform firm includ invest bank incom seek
updat research appropri variou regul may prevent us asid certain industri report publish
period basi larg major report publish irregular interv appropri analyst judgement
articl articl
explan jefferi rate
buy describ secur expect provid total return price appreci plu yield within period
hold describ secur expect provid total return price appreci plu yield plu minu within
under-perform describ secur expect provid total return price appreci plu yield minu less within
expect total return price appreci plu yield buy rate secur averag secur price consist
within period compani typic volatil overal stock market hold rate
secur averag secur price consist expect total return price appreci plu yield plu minu
within period under-perform rate secur averag secur price consist expect
total return price appreci plu yield minu less within period
nr invest rate price target temporarili suspend suspens complianc applic
cs coverag suspend jefferi suspend coverag compani
nc cover jefferi cover compani
restrict describ issuer conjunct jefferi engag certain transact compani polici applic
secur regul prohibit certain type commun includ invest recommend
monitor describ secur whose compani fundament financi monitor financi project
opinion invest merit compani provid
pleas see import disclosur inform page report
